← Back to Analyst Consensus 
VRTX Buy
VERTEX PHARMACEUTICALS INC / MA
Current Price —
Implied Upside —
Analysts 39
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 2 reiterations from 2 firms
Next Earnings
Nov 2, 2026 (7 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Oct 8, 2026 | RBC Capital | maintain | Outperform → Outperform | $576 | 55% |
| Sep 28, 2026 | UBS | maintain | Buy → Buy | $615 | 54% |
| Aug 5, 2026 | Truist Securities | maintain | Buy → Buy | — | 54% |
| Aug 5, 2026 | Barclays | maintain | Overweight → Overweight | $617 | 53% |
| Aug 4, 2026 | TD Cowen | maintain | Buy → Buy | — | 54% |
| Aug 4, 2026 | Cantor Fitzgerald | maintain | Overweight → Overweight | — | 50% |
| Aug 4, 2026 | Canaccord Genuity | maintain | Hold → Hold | — | 48% |
| Jul 13, 2026 | UBS | maintain | Buy → Buy | $585 | 54% |
| Jul 13, 2026 | Truist Securities | maintain | Buy → Buy | $560 | 54% |
| Jul 7, 2026 | RBC Capital | maintain | Outperform → Outperform | $570 | 55% |
| Jul 7, 2026 | Baird | maintain | Underperform → Underperform | — | 55% |
| May 6, 2026 | Barclays | maintain | Overweight → Overweight | $615 | 53% |
| May 5, 2026 | Canaccord Genuity | maintain | Hold → Hold | $436 | 48% |
| May 5, 2026 | Morgan Stanley | maintain | Overweight → Overweight | $616 | 54% |
| May 5, 2026 | Bernstein | maintain | Outperform → Outperform | $572 | 52% |
| May 5, 2026 | RBC Capital | maintain | Outperform → Outperform | $543 | 55% |
| Apr 30, 2026 | Canaccord Genuity | maintain | Hold → Hold | $437 | 48% |
| Apr 10, 2026 | Morgan Stanley | maintain | Overweight → Overweight | $612 | 54% |
| Mar 18, 2026 | Maxim Group | upgrade | Hold → Buy | $575 | 42% |
| Mar 11, 2026 | Truist Securities | maintain | Buy → Buy | $525 | 54% |
| Mar 10, 2026 | Morgan Stanley | maintain | Overweight → Overweight | $596 | 54% |
| Mar 10, 2026 | B of A Securities | maintain | Buy → Buy | $598 | 53% |
| Mar 10, 2026 | Citigroup | maintain | Buy → Buy | $585 | 54% |
| Mar 10, 2026 | Oppenheimer | maintain | Outperform → Outperform | $600 | 52% |
| Mar 10, 2026 | Jefferies | initiate | — → Buy | $580 | 52% |
| Mar 10, 2026 | HC Wainwright & Co. | maintain | Buy → Buy | $641 | 44% |
| Feb 17, 2026 | Canaccord Genuity | maintain | Hold → Hold | $441 | 48% |
| Feb 17, 2026 | Barclays | maintain | Overweight → Overweight | $607 | 53% |
| Feb 17, 2026 | HC Wainwright & Co. | maintain | Buy → Buy | $591 | 44% |
| Feb 17, 2026 | HC Wainwright& Co. | maintain | Buy → Buy | $591 | — |
| Feb 13, 2026 | Scotiabank | maintain | Sector Perform → Sector Perform | $558 | 55% |
| Feb 13, 2026 | RBC Capital | maintain | Outperform → Outperform | $541 | 55% |
| Feb 13, 2026 | Stifel | maintain | Hold → Hold | $466 | 53% |
| Feb 13, 2026 | Oppenheimer | upgrade | Perform → Outperform | $540 | 52% |
| Feb 13, 2026 | HC Wainwright & Co. | maintain | Buy → Buy | $518 | 44% |
| Jan 28, 2026 | Barclays | upgrade | Equal-Weight → Overweight | $606 | 53% |
| Jan 26, 2026 | UBS | maintain | Buy → Buy | $545 | 54% |
| Jan 23, 2026 | Evercore ISI Group | maintain | Outperform → Outperform | $530 | 58% |
| Jan 22, 2026 | RBC Capital | upgrade | Sector Perform → Outperform | $546 | 55% |
| Jan 12, 2026 | Bernstein | upgrade | Market Perform → Outperform | $0 | 52% |
| Jan 6, 2026 | Wolfe Research | upgrade | Peer Perform → Outperform | $548 | 53% |
| Dec 29, 2025 | Leerink Partners | maintain | Outperform → Outperform | $525 | 51% |
| Dec 10, 2025 | Wells Fargo | maintain | Overweight → Overweight | $515 | 54% |
| Dec 5, 2025 | Morgan Stanley | maintain | Overweight → Overweight | $564 | 54% |
| Dec 3, 2025 | Morgan Stanley | upgrade | Equal-Weight → Overweight | $516 | 54% |
| Nov 7, 2025 | UBS | maintain | Buy → Buy | $546 | 54% |
| Nov 4, 2025 | RBC Capital | maintain | Sector Perform → Sector Perform | $415 | 55% |
| Nov 4, 2025 | Barclays | maintain | Equal-Weight → Equal-Weight | $414 | 53% |
| Nov 4, 2025 | Stifel | maintain | Hold → Hold | $445 | 53% |
| Oct 10, 2025 | Morgan Stanley | maintain | Equal-Weight → Equal-Weight | $438 | 54% |
Price Target Trend
Aug 23, 2026 Oct 26, 2026
EPS Estimates
0q —
0y —
+1q —
+1y —
Cross-Platform Signals
No cross-platform signals in the last 90 days